Ralph MPH - Virios Therapeutics Senior Operations
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Executive
Ralph MPH is Senior Operations of Virios Therapeutics Llc
| Age | 55 |
| Phone | 866 620 8655 |
| Web | https://www.virios.com |
Virios Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.6776) % which means that it has lost $0.6776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1956) %, meaning that it created substantial loss on money invested by shareholders. Virios Therapeutics' management efficiency ratios could be used to measure how well Virios Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Virios Therapeutics Llc currently holds 358.55 K in liabilities. Virios Therapeutics Llc has a current ratio of 4.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Virios Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Calais Pharm | Transcode Therapeutics | 65 | |
| Theresa Lowry | Zura Bio Limited | 50 | |
| David Marks | Immix Biopharma | N/A | |
| Stephen McAndrew | Sonnet Biotherapeutics Holdings | 70 | |
| Tim Varacek | LMF Acquisition Opportunities | N/A | |
| Melda Oconnell | ZyVersa Therapeutics | N/A | |
| Kimberly Davis | Zura Bio Limited | 56 | |
| Gerhard Bauer | Immix Biopharma | N/A | |
| Tom Mullen | LMF Acquisition Opportunities | N/A | |
| MD FACC | ZyVersa Therapeutics | 74 | |
| Alan Freidman | Transcode Therapeutics | N/A | |
| Verender Badial | Zura Bio Limited | 52 | |
| Michael Howell | Zura Bio Limited | 47 | |
| Sai Iyer | LMF Acquisition Opportunities | N/A | |
| Gael Hedou | Sonnet Biotherapeutics Holdings | 52 | |
| David Brady | Zura Bio Limited | N/A | |
| Daniel MD | Transcode Therapeutics | 72 | |
| Covadonga Paneda | Altamira Therapeutics | 50 | |
| Gary Whale | Zura Bio Limited | 50 | |
| Linda Mahoney | Phio Pharmaceuticals Corp | N/A | |
| RN MBA | Transcode Therapeutics | N/A | |
Management Performance
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 |
Virios Therapeutics Llc Leadership Team
Elected by the shareholders, the Virios Therapeutics' board of directors comprises two types of representatives: Virios Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Virios. The board's role is to monitor Virios Therapeutics' management team and ensure that shareholders' interests are well served. Virios Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Virios Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gregory Duncan, Chairman CEO | ||
| Carol Duffy, Chief Advisor | ||
| William MD, Founder Director | ||
| Ralph MPH, Senior Operations | ||
| Angela Walsh, SVP CFO |
Virios Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Virios Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 | |||
| Current Valuation | 1.28 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 6.74 % | |||
| Shares Owned By Institutions | 3.60 % | |||
| Number Of Shares Shorted | 469.93 K | |||
| Price To Book | 1.37 X | |||
| EBITDA | 150.9 K | |||
| Net Income | (5.3 M) |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |